Biodegradable film reduces surgical scarring

A new, biodegradable film designed to reduce the severity of scarring following open heart surgery in young children appears to be safe and effective, according to researchers attending the annual meeting of the Society of Thoracic Surgeons in Ft. Lauderdale.

Scarring is a normal response to surgery, but it can be troublesome in children born with congenital heart defects because many need multiple surgeries to correct or treat their problems. “Often the scarring is severe enough that when we perform a second surgery, we find the heart is stuck to the sternum,” says Dr. Andrew Lodge, a pediatric cardiothoracic surgeon at Duke University Medical Center and study leader.

Lodge says widespread scarring, or adhesions, can mean higher risk for the patient, more time in surgery and more difficult work for the surgeons. “With adhesions, we have to cut through tough, fibrous tissue in very delicate areas – not just between the heart and the sternum, but also in other areas between vessels and cardiac chambers. This increases the amount of time a patient has to be under anesthesia and potentially could involve more bleeding and the need for transfusion or other blood products,” says Lodge. “So we are very interested in anything that can keep scarring to a minimum.”

Biomedical engineers have searched years for a solution, but so far, nothing has worked very well, says Lodge. “Right now, if we use anything we usually use a non-absorbable membrane made of Gore-Tex that we place between the heart and the sternum, but it’s not ideal.” He says anything foreign that’s left in the body can provoke an inflammatory response or invite infection and “that’s why the idea of an absorbable film is so attractive.”

Researchers at 15 institutions around the U.S. evaluated the new barrier film, called Repel-CV® Adhesion Barrier, in 103 infants undergoing open-heart surgery who were expected to undergo a second procedure. Roughly half were randomized into the treatment group and the others served as controls. Using a graded scale of none, mild, moderate or severe, physicians evaluated the extent of adhesions during the children’s second surgery, from two to three months later.

They found that use of the Repel-CV® dramatically reduced the incidence of severe scarring, with only 30 per cent of those receiving the barrier film experiencing severe scarring, compared to 71 percent of the patients in the control group. They also found that patients who underwent cardiopulmonary bypass or a Norwood procedure, as well as patients whose incisions were closed after some delay, were at higher risk of developing dense scarring in the chest, but that Repel-CV® was effective in reducing adhesions in these patients as well.

Investigators did not note any side effects from use of the new film. The product has not yet been approved by the FDA, although an application for approval has been accepted.

Source: Duke University

Related stories:

Cartilage that repairs itself? New research reveals important clues
A strain of mice with the natural ability to repair damaged cartilage may one day lead to significant improvements in treatment of human knee, shoulder and hip injuries.
Gallbladder removed without external incisions
In April of last year, surgeons at NewYork-Presbyterian Hospital/Columbia University Medical Center made headlines by removing a women's gallbladder through her uterus using a flexible endoscope, aided by several external incisions for added visibility. Now, they have performed the same procedure without a single external incision in what surgeons report may be the first surgery of its kind in the United States.
Glaucoma surgery studied in medicare patients, new hope for people
Ophthalmologists (Eye M.D.s) continue to develop treatments to help the more than three million Americans with glaucoma. The July issue of Ophthalmology includes a large, national study of outcomes of incisional surgeries, used to reduce pressure inside the eye, in Medicare patients. Also covered is research that may brighten the outlook for patients with end-stage glaucoma.
Study concludes no racial disparities in long-term outcomes in recipients of liver transplants
New research published in the Journal of the American College of Surgeons shows long-term survival and liver rejection rates are equivalent for African-American liver transplant patients as compared with patients of other races. The study also suggests that although other factors such as liver cancer or hepatitis may negatively influence long-term survival, race does not.
New surgery improves head and neck cancer treatment
A new surgical procedure for head and neck cancer at the University of Alabama at Birmingham offers improved accuracy for surgeons and reduced post-operative pain for patients.
Futuristic robots, friend or foe?
A leading robotics expert will outline some of the ethical pitfalls of near-future robots to a Parliamentary group today at the House of Commons. Professor Noel Sharkey from the University of Sheffield will explain that robots are in many ways beneficial to mankind, but there are limitations and we should proceed with caution.
2 new therapies show promise for cancer patients
Clinical researchers at Scottsdale Healthcare and TGen today announced the results of two clinical trials that show promise for patients battling cancer.
UT Southwestern surgeons complete North Texas' first single-incision gallbladder removal
UT Southwestern Medical Center surgeons have removed a gallbladder through a unique operation requiring only a single incision in the bellybutton rather than the traditional four incisions in the abdomen. It is the first such operation in North Texas.

News discussion:

Medicine & Health news